利索-全球专利检索

  1. 登录
  2. 注册

搜索结果

43 条记录 (耗时 0.034 秒)

    Anticholinergics, processes for the preparation thereof, and pharmaceutical compositions
    4.
    发明授权
    Anticholinergics, processes for the preparation thereof, and pharmaceutical compositions 有权
    抗胆碱能药，其制备方法和药物组合物

    公开(公告)号：US06696462B2

    公开(公告)日：2004-02-24

    申请号：US10345911

    申请日：2003-01-16

    申请人： Christian Eickmeier ,  Sabine Germeyer ,  Matthias Grauert ,  Sabine Pestel ,  Michael P. Pieper ,  Georg Speck ,  Steffen Breitfelder

    发明人： Christian Eickmeier ,  Sabine Germeyer ,  Matthias Grauert ,  Sabine Pestel ,  Michael P. Pieper ,  Georg Speck ,  Steffen Breitfelder

    IPC分类号： A61K31439

    CPC分类号： C07D451/06 ,  C07D451/10

    摘要： A compound of formula 1 wherein: X- is an anion with a single negative charge; A and B, which are identical or different, are each —O—, —S—, —NH—, —CH2—, —CH═CH—, or —N(C1-C4-alkyl)—; R is hydrogen, hydroxy, —C1-C4-alkyl, —C1-C4-alkyloxy, —C1-C4-alkylene-halogen, —0—C1-C4-alkylene-halogen, —C1-C4-alkylene-OH, —CF3, —CHF2, —C1-C4-alkylene-C1-C4-alkyloxy, —0—COC1-C4-alkyl, —0—COC1-C4-alkylene-halogen, —C1-C4-alkylene-C3-C6-cycloalkyl, —0—COCF3, or halogen; R1 and R2, which are identical or different, are each —C1-C5-alkyl, which is optionally substituted by —C3-C6-cycloalkyl, hydroxy, or halogen, or R1 and R2 together are a —C3-C5-alkylene bridge; R3, R4, R3′, and R4′, which are identical or different, are each hydrogen, C1-C4-alkyl, C1-C4-alkyloxy, hydroxy, —CF3, —CHF2, —CN, —NO2, or halogen; RX and RX′, which are identical or different, are each hydrogen, C1-C4-alkyl, C1-C4-alkyloxy, hydroxy, —CF3, —CHF2, —CN, —NO2, or halogen, or RX and RX′ together are a single bond or a bridging group selected from —O—, —S—, —NH—, —CH2—, —CH2—CH2—, —N(C1-C4-alkyl)—, —CH(C1-C4-alkyl)—, and —C(C1-C4-alkyl)2—, or a pharmacologically acceptable acid addition salt thereof, processes for preparing, them and their use in pharmaceutical compositions.

    摘要翻译： 式1的化合物，其中X 1是具有单个负电荷的阴离子; A和B相同或不同，各自为-O - ， - S - ， - NH-， - CH 2 - ， - CH = CH-或-N（C 1 -C 4 - 烷基） - ; R是氢，羟基，-C 1 -C 4 - 烷基，-C 1 -C 4 - 烷氧基，-C 1 -C 4 - 亚烷基 - 卤素，-O-C 1 -C 4 - 亚烷基 - 卤素，-C 1 -C 4 - 亚烷基-OH，-CF 3，-CHF 2，-C 1 -C 4 - 亚烷基-C 1 -C 4 - 烷氧基，-O-CCl-C 4 - 烷基，-O-CCl- - 卤素，-C 1 -C 4 - 亚烷基-C 3 -C 6 - 环烷基，-O-COCF 3或卤素; R 1和R 2各自为-C 1 -C 5 - 烷基， 任选被-C 3 -C 6 - 环烷基，羟基或卤素取代，或R 1和R 2一起是-C 3 -C 5亚烷基桥; R 3，R 4，R 3' R 1，R 2，R 3，R 4，R 4，R 4，R 4，R 4， X，R 1，R 2，R 2，R 2，R 2，R 3，R 3，R 3，R 3，R 3， X>和R X'一起是单键 或选自-O - ， - S - ， - NH - ， - CH 2 - ， - CH 2 -CH 2 - ， - N（C 1 -C 4 - 烷基） - ， - CH（C 1 -C 4烷基） 和-C（C 1 -C 4 - 烷基）2-或其药理学上可接受的酸加成盐，用于制备它们及其在药物组合物中的用途。